Craig-Hallum Maintains Buy on Cerence, Raises Price Target to $145
Craig-Hallum analyst Jeff Van Rhee maintains Cerence (NASDAQ:CRNC) with a Buy and raises the price target from $135 to $145.
10 Biggest Price Target Changes For Tuesday
Rosenblatt raised the price target on The Trade Desk, Inc. (NASDAQ: TTD) from $40 to $60. Trade Desk shares rose 1.1% to $82.20 in pre-market trading.
RBC Capital Maintains Sector Perform on Cerence, Raises Price Target to $114
RBC Capital analyst Joseph Spak maintains Cerence (NASDAQ:CRNC) with a Sector Perform and raises the price target from $105 to $114.
Needham Maintains Buy on Cerence, Raises Price Target to $165
Needham analyst Rajvindra Gill maintains Cerence (NASDAQ:CRNC) with a Buy and raises the price target from $155 to $165.
Cerence Beats On Q3 Earnings, Notes Margin Expansion, 13% Billings Per Car Growth
Cerence Inc (NASDAQ:CRNC) reported third-quarter FY21 revenue growth of 28.7% year-on-year to $96.8 million, beating the analyst consensus of $96.3 million.…
Cerence Sees Q4 Sales $97M-$101M vs $98.4M Est.
Fourth Quarter Fiscal 2021
For the fiscal quarter ending September 30, 2021, Revenue is expected to be in the range of $97M to $101M representing a 6% to 11% increase compared to the same period in the prior year. GAAP
Cerence Q3 Adj. EPS $0.62 Beats $0.54 Estimate, Sales $96.80M Beat $96.27M Estimate
Cerence (NASDAQ:CRNC) reported quarterly earnings of $0.62 per share which beat the analyst consensus estimate of $0.54 by 14.81 percent. This is a 100 percent increase over earnings of $0.31 per share from the same
Recap: Cerence Q3 Earnings
Shares of Cerence (NASDAQ:CRNC) remained unaffected after the company reported Q3 results.
Quarterly Results
Earnings per share were up 100.00% over the past year to $0.62, which beat the estimate of $0.54.
Earnings Scheduled For August 9, 2021
Companies Reporting Before The Bell
• Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $1.57 per share on revenue of $215.17 million.